![](/img/cover-not-exists.png)
Clinical results for tocilizumab over one year in the clinical setting as assessed by CDAI (clinical disease activity index): CRP at week 12 and MMP-3 at week 24 are predictive factors for CDAI
Atsushi Kaneko, Daihei Kida, Kiwamu Saito, Masami Tsukamoto…Volume:
32
Language:
english
DOI:
10.1007/s00296-011-2256-5
Date:
November, 2012
File:
PDF, 465 KB
english, 2012